ExScale Biospecimen Solutions
Uppsala, Uppsala Lan, Sweden
About ExScale Biospecimen Solutions
ExScale Biospecimen Solutions provide the market with process knowledge and unique chemical technology for large-scale, uncomplicated preparation of DNA and/or RNA. ExScale introduces automated, next-generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded (FFPE) tissue sections using paramagnetic beads. The technology enables serial extraction of DNA and RNA from the same biospecimen where the isolated nucleic acids are of optimal quality for next-generation sequencing and other downstream applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Jan 2013)
- Website: exscalebio.com
- Phone: [email protected]
Industries & Categories
Chemical, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/exscale-biospecimen-solutions-2550645 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.